Comparison 3. IGIV versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Mortality within 30 days | 1 | 100 | Risk Ratio (M‐H, Random, 95% CI) | 1.17 [0.42, 3.23] |
2 Proportion of patients who experienced serious adverse events | 1 | 100 | Risk Ratio (M‐H, Random, 95% CI) | 0.73 [0.32, 1.65] |